Clinical trial on Koarai vatham

An Open labelled double arm non-randomised phase II clinical trial to compare the efficacy of VARMA MANIPULATION with KARUNKURINJI KUDINEER (INTERNAL)and ETTI PATTAI ENNAI (EXTERNAL) in the treatment of KOARAI VATHAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019586

Enrollment

Registered

2019-06-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M472- Other spondylosis with radiculopathy

Interventions

Intervention1: varma manipulation for 48 days intermittently With internal medicine and external oil: Varma manipulation intermittently for 48 days With karunkurinji kudineer internal Dose-90ml bd(bef

Eligibility

Inclusion criteria

Inclusion criteria: Patients having symptoms of Pain in the lumbar region, Radiating pain to buttocks and lower limbs ,stiffness present in lumbar region, Exacerbation of pain on movements, Pain increased on forward bending, Tingling sensation.(Numbness) Patients who are willing to give radiological investigation and provide blood for lab investigation. Patient willing to sign the informed consent stating that he/she will conscientiously stick to the treatment during 48 days but can option out of the trial of his/her own conscious discretion.

Exclusion criteria

Exclusion criteria: Auto immune diseases like Rheumatoid arthiritis, SLE, Psoriasis, Mixed connective tissue disorder. Spina bifida Pregnancy and lactation Osteo myelitis Renal Disease Tuberculosis in spine Patient with any other serious illness

Design outcomes

Primary

Measure	Time frame
Assessment of change from baseline in QUEBEC BACK PAIN DISABILITY SCALE at day of between Group I and Group II for varma manipulation and internal and external medicineTimepoint: Group I Intermittent varma manipulation within 48 days 1st sitting 50 percentage of symptoms will reduce 2nd sitting 80 percentage of symptoms will reduce Group II After giving internal and external medine for 12 days with varma manipulation 50 percentage of primary symptoms will reduce within 48 days 80 percentage of symptoms will reduce	—

Measure

Time frame

Assessment of change from baseline in QUEBEC BACK PAIN DISABILITY SCALE at day of between Group I and Group II for varma manipulation and internal and external medicineTimepoint: Group I Intermittent varma manipulation within 48 days 1st sitting 50 percentage of symptoms will reduce 2nd sitting 80 percentage of symptoms will reduce Group II After giving internal and external medine for 12 days with varma manipulation 50 percentage of primary symptoms will reduce within 48 days 80 percentage of symptoms will reduce

—

Secondary

Measure	Time frame
Assessment of OSWESTRY LOWBACK PAIN DISABILITY QUESTIONNAIRE. Assessment of safety parametersTimepoint: Group I Intermittent varma manipulation within 48 days 1st sitting 50 percentage of symptoms will reduce 2nd sitting 80 percentage of symptoms will reduce Group II After giving internal and external medine for 12 days with varma manipulation 50 percentage of primary symptoms will reduce within 48 days 80 percentage of symptoms will reduce	—

Measure

Time frame

Assessment of OSWESTRY LOWBACK PAIN DISABILITY QUESTIONNAIRE. Assessment of safety parametersTimepoint: Group I Intermittent varma manipulation within 48 days 1st sitting 50 percentage of symptoms will reduce 2nd sitting 80 percentage of symptoms will reduce Group II After giving internal and external medine for 12 days with varma manipulation 50 percentage of primary symptoms will reduce within 48 days 80 percentage of symptoms will reduce

—

Countries

India

Contacts

Public ContactS SUJATHA

GOVT SIDDHA MEDICAL COLLEGE AND HOSPITAL PALAYAMKOTTAI TIRUNELVELI

rajasekarsujatha@gmail.com9442331462

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026